Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters


Cancer Drug Resistance Is Now a Member of the Committee on Publication Ethics

Published on: 15 Mar 2019 Viewed: 1980

We are pleased to announce that the journal of Cancer Drug Resistance is Now a member of the Committee on Publication Ethics (COPE). Please see details at:

COPE, a registered charity, established in 1997 in the United Kingdom, has over 7,000 members worldwide from all academic fields. COPE provides advice to editors and publishers on all aspects of publication ethics and, in particular, how to handle cases of research and publication misconduct.

Cancer Drug Resistance will adhere to the COPE Code of Conduct ( ) and also follow the Best Practice Guidelines for Journal Editors ( ensuring that our editors enforce a rigorous peer-review process with strict ethical policies.

© 2016-2021 OAE Publishing Inc., except certain content provided by third parties